Dr. Carey A. Dellock, MD

Dr. Dellock practices at HCA Florida Capital Hospital in Tallahassee, Florida, part of HCA Healthcare.

Dr. Dellock's NPI, 1003879131, was assigned on April 10, 2006. Dr. Dellock graduated from Penn State College of Medicine in 1998. Dr. Dellock holds Florida license ME110641.

Dr. Dellock's primary practice is HCA Florida Capital Hospital, at 2626 Capital Medical Blvd, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 656-5000.

Dr. Dellock's primary practice is HCA Florida Capital Hospital in Tallahassee, Florida, part of HCA Healthcare. Dr. Dellock is also affiliated with Southeast Health Medical Center. The medical group on file is Capital Regional Cardiology Associates. Dmand AI also links Dr. Dellock to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dellock practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dellock's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dellock is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Dellock's licenses on file in 4 states: Florida, Georgia, Pennsylvania and North Carolina.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and endocarditis among the conditions Dr. Dellock treats.

CMS data shows 993 Medicare services from Dr. Dellock across 17 procedure codes in 2024, for 489 Medicare patients. Medicare paid $79,773 for them.

CMS counts 489 Medicare patients who saw Dr. Dellock in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dellock's median patient age at 71, with 52% women.

In 2024, Dr. Dellock wrote 790 Medicare Part D claims for 221 patients. 80% of them were for generic drugs. CMS names the drug for 574 of them, across 18 drugs with 11 or more claims each, at $127,746 in total drug cost. In 2023, CMS named 720 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dellock for performance year 2024, reported individually. Dr. Dellock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of coronary angioplasty and stenting by Dr. Dellock, more than 53% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Dellock. The most frequent topics are Administration, Oral and Kidney Transplantation. Dr. Dellock has published most often in Transplant Proc.

CMS Open Payments shows 572 general payments to Dr. Dellock from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Medtronic, Inc. paid the most, $3,331.

Dmand AI lists 1 award for Dr. Dellock.

Dr. Dellock graduated from Penn State College of Medicine in 1998. Dr. Dellock is a member of ACC.

Dr. Dellock is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.